Louise H. Boyle

1.7k total citations
36 papers, 1.3k citations indexed

About

Louise H. Boyle is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Louise H. Boyle has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 11 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Louise H. Boyle's work include Immune Cell Function and Interaction (17 papers), T-cell and B-cell Immunology (16 papers) and Immunotherapy and Immune Responses (15 papers). Louise H. Boyle is often cited by papers focused on Immune Cell Function and Interaction (17 papers), T-cell and B-cell Immunology (16 papers) and Immunotherapy and Immune Responses (15 papers). Louise H. Boyle collaborates with scholars based in United Kingdom, Portugal and Germany. Louise H. Boyle's co-authors include John Trowsdale, Andreas Neerincx, Clemens Hermann, Jane Goodall, Janet E. Deane, Jessica M. Boname, Paul J. Lehner, Marian L. Burr, Mark R. Wills and J. S. Hill Gaston and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Louise H. Boyle

34 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Louise H. Boyle United Kingdom 22 873 458 243 147 127 36 1.3k
Lourdes Planelles Spain 19 587 0.7× 294 0.6× 217 0.9× 213 1.4× 79 0.6× 22 1.1k
Chantal Bella France 19 1.0k 1.2× 364 0.8× 230 0.9× 161 1.1× 66 0.5× 20 1.4k
Mirjana Weimershaus France 11 502 0.6× 287 0.6× 129 0.5× 193 1.3× 62 0.5× 17 747
Takuya Nojima Japan 16 754 0.9× 378 0.8× 85 0.3× 199 1.4× 55 0.4× 28 1.3k
Virginie Prod’homme France 17 903 1.0× 296 0.6× 657 2.7× 298 2.0× 49 0.4× 23 1.5k
Devina Divekar United Kingdom 5 992 1.1× 185 0.4× 129 0.5× 148 1.0× 66 0.5× 10 1.3k
Ulrike Samulowitz Germany 15 645 0.7× 486 1.1× 113 0.5× 120 0.8× 37 0.3× 19 1.2k
Josiane Ragimbeau France 15 746 0.9× 304 0.7× 137 0.6× 369 2.5× 117 0.9× 20 1.2k
Irini Evnouchidou France 18 701 0.8× 466 1.0× 373 1.5× 480 3.3× 297 2.3× 32 1.3k
Natividad Longo Spain 18 831 1.0× 330 0.7× 96 0.4× 445 3.0× 32 0.3× 23 1.4k

Countries citing papers authored by Louise H. Boyle

Since Specialization
Citations

This map shows the geographic impact of Louise H. Boyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise H. Boyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise H. Boyle more than expected).

Fields of papers citing papers by Louise H. Boyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louise H. Boyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise H. Boyle. The network helps show where Louise H. Boyle may publish in the future.

Co-authorship network of co-authors of Louise H. Boyle

This figure shows the co-authorship network connecting the top 25 collaborators of Louise H. Boyle. A scholar is included among the top collaborators of Louise H. Boyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise H. Boyle. Louise H. Boyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boyle, Louise H., et al.. (2023). Get into the groove! The influence of TAPBPR on cargo selection. Current Opinion in Immunology. 83. 102346–102346. 2 indexed citations
2.
Hutchings, Maggie, et al.. (2023). Interprofessional education after the pandemic: lessons learned and future considerations. British Journal of Midwifery. 31(9). 519–529.
3.
Boyle, Louise H., et al.. (2021). Why TAPBPR? Implications of an additional player in MHC class I peptide presentation. Current Opinion in Immunology. 70. 90–94. 7 indexed citations
4.
Boyle, Louise H., et al.. (2021). The glycosylation status of MHC class I molecules impacts their interactions with TAPBPR. Molecular Immunology. 139. 168–176. 7 indexed citations
5.
Boyle, Louise H., et al.. (2020). The Ins and Outs of TAPBPR. Current Opinion in Immunology. 64. 146–151. 7 indexed citations
6.
Neerincx, Andreas, et al.. (2018). Utilizing TAPBPR to promote exogenous peptide loading onto cell surface MHC I molecules. Proceedings of the National Academy of Sciences. 115(40). E9353–E9361. 28 indexed citations
7.
Casey, Ruth, Olivier Giger, Ian Seetho, et al.. (2018). Rapid disease progression in a patient with mismatch repair-deficient and cortisol secreting adrenocortical carcinoma treated with pembrolizumab. Seminars in Oncology. 45(3). 151–155. 23 indexed citations
8.
Neerincx, Andreas, Clemens Hermann, Ana Marcu, et al.. (2018). TAPBPR mediates peptide dissociation from MHC class I using a leucine lever. eLife. 7. 37 indexed citations
9.
Neerincx, Andreas & Louise H. Boyle. (2017). Properties of the tapasin homologue TAPBPR. Current Opinion in Immunology. 46. 97–102. 33 indexed citations
10.
Hermann, Clemens, John Trowsdale, & Louise H. Boyle. (2015). TAPBPR: a new player in the MHC class I presentation pathway. Tissue Antigens. 85(3). 155–166. 23 indexed citations
11.
Porter, Keith, Clemens Hermann, James A. Traherne, & Louise H. Boyle. (2014). TAPBPR isoforms exhibit altered association with MHC class I. Immunology. 142(2). 289–299. 7 indexed citations
12.
Boyle, Louise H., Clemens Hermann, Jessica M. Boname, et al.. (2013). Tapasin-related protein TAPBPR is an additional component of the MHC class I presentation pathway. Proceedings of the National Academy of Sciences. 110(9). 3465–3470. 92 indexed citations
13.
Hermann, Clemens, et al.. (2013). The Binding of TAPBPR and Tapasin to MHC Class I Is Mutually Exclusive. The Journal of Immunology. 191(11). 5743–5750. 43 indexed citations
14.
Jones, Des C., Vasilis Kosmoliaptsis, Richard Apps, et al.. (2011). HLA Class I Allelic Sequence and Conformation Regulate Leukocyte Ig-Like Receptor Binding. The Journal of Immunology. 186(5). 2990–2997. 106 indexed citations
15.
Boyle, Louise H., Alison K. Gillingham, Sean Munro, & John Trowsdale. (2006). Selective Export of HLA-F by Its Cytoplasmic Tail. The Journal of Immunology. 176(11). 6464–6472. 74 indexed citations
16.
Valés‐Gómez, Mar, Adam Winterhalter, Pedro Roda‐Navarro, et al.. (2005). The human cytomegalovirus glycoprotein UL16 traffics through the plasma membrane and the nuclear envelope. Cellular Microbiology. 8(4). 581–590. 19 indexed citations
17.
Boyle, Louise H., Jane Goodall, & J. S. Hill Gaston. (2004). Major histocompatibility complex class I‐restricted alloreactive CD4+ T cells. Immunology. 112(1). 54–63. 29 indexed citations
18.
Boyle, Louise H., Jane Goodall, & J. S. Hill Gaston. (2004). The Recognition of Abnormal Forms of HLA-B27 by CD4+ T Cells. Current Molecular Medicine. 4(1). 51–58. 22 indexed citations
19.
Boyle, Louise H.. (2003). Breaking the rules: the unconventional recognition of HLA-B27 by CD4+ T lymphocytes as an insight into the pathogenesis of the spondyloarthropathies. British journal of rheumatology. 42(3). 404–412. 23 indexed citations
20.
Boyle, Louise H., Jane Goodall, Stephen Opat, & J. S. Hill Gaston. (2001). The Recognition of HLA-B27 by Human CD4+ T Lymphocytes. The Journal of Immunology. 167(5). 2619–2624. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026